Abstract
Biological monitoring of workers exposed toN,N-dimethylformamide (DMF) was carried out by determination of the urinary metabolites,N-methylformamide (MF, mainly fromN-hydroxymethylformamide) andN-acetyl-S-(N-methylcarbamoyl)cysteine (AMCC), which were derived from two different routes of metabolism of the solvent. The urinary levels of MF increased rapidly at the start of the work shift, and decreased almost to zero within 24 h after the beginning of the last exposure. The highest level was found between the end of the afternoon shift and bedtime. AMCC levels remained constant over the consecutive work days and increased after the cessation of exposure, with the peak concentration being observed at 16–40 h after the cessation of exposure. AMCC levels at the beginning of the next morning shift were closely correlated with personal exposure levels of DMF in air, although the correlation of MF and DMF in air was highest in the urine at the end of the shift. Hence urinary AMCC represents an index of the average exposure during several preceding work days and may indicate the internal dose. By contrast, MF represents an index of daily exposure.
This is a preview of subscription content, log in via an institution to check access.
References
American Conference of Governmental Industrial Hygienists (1993) Threshold limit values and biological exposure indices for 1993–1994. Cincinnati, USA
Cross H, Dayal R, Hyland R, Gescher A (1990)N-Alkylformamides are metabolized toN-alkylcarbomylating species by hepatic microsomes from rodents and humans. Chem Res Toxicol 3:357–362
Fleming LE, Shalat SL, Redlich CA (1990) Liver injury in workers exposed to dimethylformamide. Scand J Work Environ Health 16:289–292
International Agency for Research on Cancer (1989) IARC monographs on the evaluation of carcinogenic risk to humans, vol 47. IARC, Lyon, pp 171–197
Gescher A (1993) Metabolism ofN,N-dimethylformamide: key to the understanding of its toxicity. Chem Res Toxicol 6:245–251
Kawai T, Yasugi T, Mizunuma K, Watanabe T, Cai S-X, Huang M-Y, Xi L-Q, Qu J-B, Yao B-Z, Ikeda M (1992) Occupational dimethylformaide exposure. 2. Monomethylformamide excretion in urine after occupational dimethylformamide exposure. Int Arch Occup Environ Health 63:455–460
Kestell P, Gill MH, Threadgill MD, Gesher A, Howarth OW, Curzon EH (1986) Identification by proton NMR ofN-(hy-droxymethyl)-N-methylformamide as the major urinary metabolite of N,N-dimethylformamide in mice. Life Sci 38:719–724
Kestell P, Threadgill MD, Gescher A, Gledhill AP, Shaw AJ, Farmer PB (1986) An investigation of the relation between the hepatotoxicity and the metabolism ofN-alkylformamides. J Pharmacol Exp Ther 240:265–270
Lauwerys RR, Kivits A, Lhoir M, Rigolet P, Houbeau D, Buchet JP, Roles HA (1980) Biological surveillance of workers exposed to dimethylformamide and the influence of skin protection on its percutaneous absorption. Int Arch Occup Environ Health 45:189–203
Mraz J, Turecek F (1987) Identification ofN-acetyl-S-(N-methylcarbamoyl) cysteine, a human metabolite ofN,N-dimethylformamide andN-methylformamide. J Chromatogr 414:399–404
Mraz J, Cross H, Gescher A, Threadgill MD, Flek J (1989) Deferences between rodents and humans in the metabolic toxification ofN,N-dimethylformamide. Toxicol Appl Pharmacol 98:507–516
Mraz J, Nohova H (1992) Absorption, metabolism and elimination ofN,N-dimethylformamide in humans. Int Arch Occup Environ Health 64:85–92
Mraz J (1988) Gaschromatographic method for the determination ofN-acetyl-S-(N-methylcarbamoyl)cysteine, a metabolite ofN,N-dimethylformamide andN-methylformamide, in human urine. J Chromatogr 431:361–368
Redlich CA, Beckett WS, Sparer J, Barwick KW, Riely CA, Miller H, Sigal SL, Shalat SL, Cullen MR (1988) Liver disease association with occupational exposure to the solvent dimethylfomamide. Ann Intern Med 108:680–686
Redlich CA, West AB, Fleming L, True LD, Cullen MR, Riely CA (1990) Clinical and pathological characteristics of hepatotoxicity associated with occupational exposure to dimethylformamide. Gastroenterology 99:748–757
Scailteur V, Lauwerys R (1984) In vivo metabolism of dimethylformamide and relationship to toxicity in the male rat. Arch Toxicol 56:87–91
Scailteur V, Lauwerys R (1984) In vivo and in vitro oxidative biotransformation of dimethylformamide in rat. Chem Biol Interact 50:327–337
Scailteur V, Lauwerys R (1987) Dimethylformamide (DMF) hepatotoxicity. Toxicology 43:231–238
Shaw AJ, Gescher A, Mraz J (1988) Cytotoxicity and metabolism of hepatotoxin N-methylformamide and related formamides in mouse hepatocytes. Toxicol Appl Pharmacol 95:162–170
Tulip K, Timbrell JA (1988) Comparative hepatotoxicity and metabolism ofN-methylformamide in rats and mice. Arch Toxicol 62:167–176
Wang J-D, Lai M-Y, Chen J-S, Lin J-M, Chiang J-R, Shiau S-J, Chang W-S (1991) Dimethylformamide-induced liver damage among synthetic leather workers. Arch Environ Health 46:161–166
Yonemoto J, Suzyki S (1980) Relation of exposure to dimethylformamide vapor and the metabolite, methylformamide, in urine of workers. Int Arch Occup Environ Health 467: 159–165
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sakai, T., Kageyama, H., Araki, T. et al. Biological monitoring of workers exposed toN,N-dimethylformamide by determination of the urinary metabolites,N-methylformamide andN-acetyl-S-(N-methylcarbamoyl) cysteine. Int. Arch Occup Environ Heath 67, 125–129 (1995). https://doi.org/10.1007/BF00572236
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00572236